Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GPCR
Biotech
Lilly-backed Superluminal speeds toward the clinic with $120M
The Boston-based biotech focuses on G protein-coupled receptors, which are proteins embedded in the membranes of cells.
Darren Incorvaia
Sep 9, 2024 7:00am
Avrobio's corporate tremor attracts Tectonic for reverse merger
Jan 30, 2024 3:24pm
GSK jilts Sosei, axing bowel disease drug amid immunology pivot
Nov 27, 2023 5:00am
Vertex gets in on GPCR game, paying Septerna $47M for program
Sep 12, 2023 9:05am
Septerna snags $150M series B for next-gen GPCR drugs
Jul 11, 2023 7:00am
Daiichi taps Confo to hit once-undruggable target in $182M deal
Mar 30, 2023 5:00am